C 19 H 13 NO 3 , triclinic, P1 (no. 2), a = 9.4457(6) Å, b = 11.0520 (7)
CCDC no.: 1569821The asymmetric unit of the title crystal structure is shown in the figure. Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters.
Source of materialThe title compound was obtained according to the literature method of preparation of 8,9-dimethoxy-2-nitro- was refluxed for 3 hr, and then THF was evaporated, the residues were directly charged on a chromatography column to give the pure product 1.42 g (80.5%). Colourless crystals were obtained by slow evaporation of mixed solution of dichloromethane and ethanol (volume 1:1) at room temperature.
Experimental detailsHydrogen atoms were placed geometrically and refined using a riding model with d(C-H) = 0.93-0.98 Å, U iso (H) = 1.2 U eq (C) for CH groups. The element of pseudo symmetry in the tiltle structure is a translation along the crystallographic b direction. Generally reflections hkl with k = odd are weaker than those with k = even. All over the structure the translational pseudosymmetry fit is 86% according to the CheckCif program.
DiscussionThe 3-nitrochromenes were reported to have pharmaceutically interesting properties, such as anti-breast cancer agents [5], antifungal activity [6], flavodoxin inhibitors against
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.